These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17599097)

  • 1. Prothymosin-alpha1 prevents necrosis and apoptosis following stroke.
    Fujita R; Ueda H
    Cell Death Differ; 2007 Oct; 14(10):1839-42. PubMed ID: 17599097
    [No Abstract]   [Full Text] [Related]  

  • 2. Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.
    Ueda H
    Pharmacol Ther; 2009 Sep; 123(3):323-33. PubMed ID: 19500618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothymosin alpha as robustness molecule against ischemic stress to brain and retina.
    Ueda H; Matsunaga H; Uchida H; Ueda M
    Ann N Y Acad Sci; 2010 Apr; 1194():20-6. PubMed ID: 20536446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures.
    Ueda H; Fujita R; Yoshida A; Matsunaga H; Ueda M
    J Cell Biol; 2007 Mar; 176(6):853-62. PubMed ID: 17353361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prothymosin-alpha act as molecular switch between apoptosis and autophagy?
    Piacentini M; Evangelisti C; Mastroberardino PG; Nardacci R; Kroemer G
    Cell Death Differ; 2003 Sep; 10(9):937-9. PubMed ID: 12934067
    [No Abstract]   [Full Text] [Related]  

  • 6. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition.
    Fujita R; Ueda M; Fujiwara K; Ueda H
    Cell Death Differ; 2009 Feb; 16(2):349-58. PubMed ID: 18989338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel functions of the well-known protein--prothymosin alpha is involved in protection of cells against apoptosis and oxidative stress].
    Evstaf'eva AG; Karapetian RN; Rubtsov IuP; Filonov GS; Abaeva IS; Fateeva TV; Mel'nikov SV; Chichkova NV; Vartapetian AB
    Mol Biol (Mosk); 2005; 39(5):729-45. PubMed ID: 16240708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfing on prothymosin alpha proliferation and anti-apoptotic properties.
    Letsas KP; Frangou-Lazaridis M
    Neoplasma; 2006; 53(2):92-6. PubMed ID: 16575463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke.
    Ueda H
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):315-23. PubMed ID: 18176798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages.
    Maeda S; Sasaki K; Halder SK; Fujita W; Ueda H
    J Pharmacol Sci; 2016 Sep; 132(1):100-104. PubMed ID: 27543170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of thymosin fractions on the development of compression edema-swelling of the brain].
    Platonov IA
    Eksp Klin Farmakol; 1998; 61(4):51-3. PubMed ID: 9783111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies.
    Mosoian A
    Future Med Chem; 2011 Jul; 3(9):1199-208. PubMed ID: 21806381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prothymosin alpha and tumor: current status and perspective].
    Wang M; Pan JY
    Ai Zheng; 2007 Mar; 26(3):333-6. PubMed ID: 17355803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
    Yap E; Tan WL; Ng I; Ng YK
    Brain Res; 2008 Feb; 1195():130-8. PubMed ID: 18207135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.
    Skopeliti M; Iconomidou VA; Derhovanessian E; Pawelec G; Voelter W; Kalbacher H; Hamodrakas SJ; Tsitsilonis OE
    Mol Immunol; 2009 Feb; 46(5):784-92. PubMed ID: 18976813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits.
    Lapchak PA
    Brain Res; 2007 Sep; 1167():123-8. PubMed ID: 17673188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CON: The toxic effects of anesthetics in the developing brain: the clinical perspective.
    Loepke AW; McGowan FX; Soriano SG
    Anesth Analg; 2008 Jun; 106(6):1664-9. PubMed ID: 18499595
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related decrease of striatal neurogenesis is associated with apoptosis of neural precursors and newborn neurons in rat brain after ischemia.
    Chen Y; Sun FY
    Brain Res; 2007 Aug; 1166():9-19. PubMed ID: 17662700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.